RxDoctor Payments Data

Benjamin Barnett

Family · Sardinia, OHNPI 1184292336

Payments from drug & device makers

$266in general payments, 2019–2025

Across 15 payments — averaging $17.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$81
  • Johnson & Johnson$53
  • Lilly USA, LLC$48
  • Biohaven Pharmaceuticals, Inc.$18
  • Heartflow, Inc.$16
  • Amgen$13
  • plus $37 from 3 others

What the payments were for

  • Food & beverage$266100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$266 in reported general payments places this provider in the 45th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$39,509
Medicare patients
113
Services billed
552

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban77$62,065
VraylarCariprazine Hcl27$37,642
FarxigaDapagliflozin Propanediol35$24,227
MounjaroTirzepatide14$14,377
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$11,470
XareltoRivaroxaban19$11,121
JardianceEmpagliflozin11$10,627
Breo ElliptaFluticasone/Vilanterol11$5,114
MovantikNaloxegol Oxalate11$4,651
Lantus SolostarInsulin Glargine,hum.Rec.Anlog26$3,249
Vilazodone Hcl11$2,530
Levemir FlexpenInsulin Detemir15$2,283
Albuterol Sulfate HfaAlbuterol Sulfate74$1,871
Atorvastatin Calcium240$1,588
Gabapentin122$1,263

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$81$37,64227 claims
GSKTrelegy Ellipta, Breo Ellipta$13$16,58422 claims
Lilly USA, LLCMounjaro$48$14,37714 claims
Johnson & JohnsonXarelto$53$11,12119 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 6,812 family providers in Ohio.

Other family in Sardinia

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →